Circumventing tolerance to the prion protein (PrP): vaccination with PrP-displaying retrovirus particles induces humoral immune responses against the native form of cellular PrP.
about
Selection of functional human antibodies from retroviral display librariesPrion diseases: immunotargets and therapyDendritic cell-mediated-immunization with xenogenic PrP and adenoviral vectors breaks tolerance and prolongs mice survival against experimental scrapie.Functional mechanisms of the cellular prion protein (PrP(C)) associated anti-HIV-1 properties.Prion protein-specific antibodies for therapeutic intervention of transmissible spongiform encephalopathies.Recent developments in mucosal vaccines against prion diseases.High titers of mucosal and systemic anti-PrP antibodies abrogate oral prion infection in mucosal-vaccinated mice.Potential of active and passive immunizations for the prevention and therapy of transmissible spongiform encephalopathies.The receptor attachment function of measles virus hemagglutinin can be replaced with an autonomous protein that binds Her2/neu while maintaining its fusion-helper function.Detection and control of prion diseases in food animals.Therapeutic approaches for prion disorders.Immunotherapy for prion diseases: opportunities and obstacles.Prion protein (PrP) gene-knockout cell lines: insight into functions of the PrP.DNA vaccination can break immunological tolerance to PrP in wild-type mice and attenuates prion disease after intracerebral challenge.Pro-autophagic signal induction by bacterial pore-forming toxins.Vaccination with prion peptide-displaying papillomavirus-like particles induces autoantibodies to normal prion protein that interfere with pathologic prion protein production in infected cells.Mucosal immunization with an attenuated Salmonella vaccine partially protects white-tailed deer from chronic wasting disease.Cell-based immunotherapy of prion diseases by adoptive transfer of antigen-loaded dendritic cells or antigen-primed CD(4+) T lymphocytes.Displaying Tetra-Membrane Spanning Claudins on Enveloped Virus-Like Particles for Cancer Immunotherapy.Hepatitis C virus-induced prion protein expression facilitates hepatitis C virus replication.
P2860
Q24794038-AA0FE881-8801-4B7A-93A9-CE23D5FB042DQ26741258-9B356733-631C-43AB-A26E-7E805CF279DFQ33419380-4DD5749F-79F1-4005-ADB3-51BAFB783D01Q34231846-42504A09-5EAB-4D8D-BD72-17D38896B2D8Q36407253-B8FDC526-DAFE-4E98-A80C-7687CD27EB08Q36728797-A39D7CE6-83D5-478C-94B4-165A496A13C9Q36776046-FFECDDCD-913E-4037-A09C-02426BE32BBFQ36780126-A9F731E5-AE7D-4A94-ACB1-55750BB6607CQ36827199-5A75868F-B514-481E-BCCA-CC4F102422E6Q36857700-297266BF-BF26-4D1A-8E78-3C2EE78A1E3BQ36901944-8354F0EB-6CA1-4B9F-AA4E-2C17FD27775FQ37773260-D00EF571-30CE-4759-AE8C-4144E61F8D96Q38340595-586DD88D-BBCC-4B51-9CBA-043610AE3BD3Q38761934-34D21F29-9925-46F4-B4C4-76584F67C88AQ39705919-7879241A-18E7-475C-99F4-43261180957EQ40168614-8D7AB174-FAE9-4A7B-9FDA-5AF207758592Q41582362-A8667D64-CD3C-4011-976A-7C77F963DCC3Q42432218-93981798-0621-4D44-9B14-D5D923B4EEADQ45324916-41E0C6BC-94AF-4252-A5C0-B577B5AD4D16Q45325599-CE31A898-BE8E-4BB7-ABC7-973279BC1A92
P2860
Circumventing tolerance to the prion protein (PrP): vaccination with PrP-displaying retrovirus particles induces humoral immune responses against the native form of cellular PrP.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Circumventing tolerance to the ...... e native form of cellular PrP.
@en
type
label
Circumventing tolerance to the ...... e native form of cellular PrP.
@en
prefLabel
Circumventing tolerance to the ...... e native form of cellular PrP.
@en
P2093
P2860
P50
P1433
P1476
Circumventing tolerance to the ...... he native form of cellular PrP
@en
P2093
Christian J Buchholz
Daphne Nikles
Klaus Boller
Klaus Cichutek
Patricia Bach
P2860
P304
P356
10.1128/JVI.79.7.4033-4042.2005
P407
P577
2005-04-01T00:00:00Z